SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion

Peng Wang1, Hu Wang2, Xiaotao Li3

  • 1Department of Orthopedics, The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.

Plos One
|August 12, 2016
PubMed

Insights

SRCIN1 (SRC kinase signalling inhibitor 1) acts as a tumor suppressor in osteosarcoma. Its downregulation correlates with tumor progression, while its overexpression inhibits cancer cell proliferation and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SRCIN1 (SRC kinase signalling inhibitor 1) is recognized as a tumor suppressor gene in lung and breast cancers.
  • The specific role of SRCIN1 in osteosarcoma development remains largely unexplored.

Purpose of the Study:

  • To investigate the expression levels of SRCIN1 in osteosarcoma.
  • To determine the functional role of SRCIN1 in osteosarcoma cell proliferation, epithelial-mesenchymal transition (EMT), colony formation, and invasion.

Main Methods:

  • Quantitative analysis of SRCIN1 expression in osteosarcoma cell lines and tissues.
  • Overexpression of SRCIN1 in MG-63 osteosarcoma cells.
  • Assessment of cell proliferation using Ki-67 and PCNA markers.
  • Evaluation of EMT markers (E-cadherin, N-cadherin, Vimentin, Snail).
  • Colony formation and invasion assays.

Main Results:

  • SRCIN1 expression was significantly downregulated in osteosarcoma cell lines and tissues compared to normal controls.
  • Overexpression of SRCIN1 suppressed MG-63 cell proliferation, colony formation, and invasion.
  • SRCIN1 overexpression upregulated E-cadherin and downregulated N-cadherin, Vimentin, and Snail, indicating inhibition of EMT.

Conclusions:

  • SRCIN1 functions as a tumor suppressor gene in osteosarcoma.
  • Downregulation of SRCIN1 is associated with osteosarcoma progression.
  • SRCIN1 may serve as a potential therapeutic target for osteosarcoma treatment.